Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer
暂无分享,去创建一个
G. Kristiansen | M. Dietel | H. Moch | K. Jung | K. Miller | M. Johannsen | M. Riener | H. Krause | C. Kempkensteffen | S. Hinz | S. Weikert | F. Fritzsche
[1] R. Dienstmann,et al. XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy. , 2009, Urologic oncology.
[2] G. Kristiansen,et al. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. , 2009, European urology.
[3] G. Kristiansen,et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. , 2009, European journal of cancer.
[4] G. Torzilli,et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma , 2009, BMC Cancer.
[5] G. Kristiansen,et al. Claudin-1 Protein Expression is a Prognostic Marker of Patient Survival in Renal Cell Carcinomas , 2008, Clinical Cancer Research.
[6] Haiyang Xie,et al. Predictive Value of Expression and Promoter Hypermethylation of XAF1 in Hepatitis B Virus-Associated Hepatocellular Carcinoma Treated with Transplantation , 2008, Annals of Surgical Oncology.
[7] S. Takeno,et al. Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas , 2008, Annals of Surgical Oncology.
[8] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[9] Bohuslav Melichar,et al. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial , 2007, The Lancet.
[10] G. Kristiansen,et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression , 2008, BMC Cancer.
[11] K. Miller,et al. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome. , 2007, Cancer letters.
[12] R. Korneluk,et al. Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex* , 2007, Journal of Biological Chemistry.
[13] M. Sata,et al. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. , 2007, Oncology reports.
[14] Kil Yeon Lee,et al. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. , 2007, Gastroenterology.
[15] J. Gu,et al. Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis , 2007, Cancer Gene Therapy.
[16] J. Lam,et al. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Chi,et al. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses , 2006, Oncogene.
[18] E. Borden,et al. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] C. Duckett,et al. Xaf1 can cooperate with TNFα in the induction of apoptosis, independently of interaction with XIAP , 2006, Molecular and Cellular Biochemistry.
[20] M. Qiao,et al. Low expression of XIAP-associated factor 1 in human colorectal cancers. , 2005, Chinese journal of digestive diseases.
[21] C. Tangen,et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. , 2005, The Journal of urology.
[22] M. Martinka,et al. XAF1 expression is significantly reduced in human melanoma. , 2004, The Journal of investigative dermatology.
[23] H E Gabbert,et al. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas , 2004, British Journal of Cancer.
[24] T. Ebert,et al. XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. , 2004, Human pathology.
[25] D. Vaux,et al. Cell death regulation by the mammalian IAP antagonist Diablo/Smac , 2002, Apoptosis.
[26] John Calvin Reed,et al. Endogenous Inhibitors of Caspases , 1999, Journal of Clinical Immunology.
[27] Mamta Chawla-Sarkar,et al. Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN-β Compared with IFN-α2 , 2003 .
[28] Kyucheol Cho,et al. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. , 2003, Cancer research.
[29] Mamta Chawla-Sarkar,et al. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[30] E. Borden,et al. Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis* , 2002, The Journal of Biological Chemistry.
[31] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[32] K. Tamai,et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity , 2001, Nature Cell Biology.
[33] R. Korneluk,et al. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. , 2000, Genomics.
[34] L. Schwartz,et al. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[36] J C Reed,et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[38] John Calvin Reed. Dysregulation of apoptosis in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A. MacKenzie,et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer , 1998, Oncogene.
[40] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[41] R. Motzer,et al. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] M. Karno,et al. Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.